Aquestive Therapeutics
AQST
AQST
46 hedge funds and large institutions have $18.7M invested in Aquestive Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.07% less ownership
Funds ownership: 33.87% → 29.79% (-4.1%)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
Holders
46
Holding in Top 10
2
Calls
$28K
Puts
–
Top Buyers
| 1 | +$368K | |
| 2 | +$157K | |
| 3 | +$147K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$137K |
| 5 |
Man Group
London,
United Kingdom
|
+$102K |
Top Sellers
| 1 | -$715K | |
| 2 | -$368K | |
| 3 | -$114K | |
| 4 |
D.E. Shaw & Co
New York
|
-$106K |
| 5 |
CAC
Cowen and Company
New York
|
-$80K |